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Summary
Aim: In this longitudinal study, the Role of Low Level Laser Therapy in Chronic Drug Resistant pulmonary tuberculosis has
been studied for a period of 10 years from 1995 to 2004 and follow up was done for a period of 3 years.
Material and Methods: 61 patients in Nitrogen Laser Therapy group (LLLT Group) and 61 were kept as control group.
The aim of study was to describe the efficacy and safety of low level nitrogen laser therapy in management of chronic drug
resistant pulmonary tuberculosis. All the patients, included in this study, had already taken anti-tubercular drugs for more
than one year and were still sputum smear and culture positive.
Results: Among LLLT group, 44 (72.13%) patients became sputum smear and culture negative for MTB (Mycobacterium
Tuberculosis) as compared to 26 (42.62%) in control group. Of the 44 patients, 22(50%) converted within first month.
Conclusion: Low Level Nitrogen Laser Therapy may be used as an adjuvant to anti-tubercular drugs in cases of  chronic drug
resistant  pulmonary tuberculosis.
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INTRODUCTION
Tuberculosis affects more than 8 million
people and has serious repercussion  on economy,
psychological  and social status.  Since the declaration
as  a global emergency in 1993 by the WHO,
significant development in the treatment and control
of  tuberculosis has been the implementation  of the
short course  directly observed  treatment along with
fixed  dose combination of  existing drugs.  However,
the available  therapeutic regimens have inherent
disadvantage of  long treatment  duration, results in
patient’s  non-compliance, and  yields the risk of
having drug resistance.  Hence  new modalities of
treatment that are potent, active resistant against
strain and curtailment of  treatment period  are needed
to combat this disease. In countries that are poor
MDR cases, which cannot be treated with  the
standard medicine, can be a death sentence. MDR -
PTB (Multi Drug Resistant Pulmonary Tuberculosis)
is at least  50 times more expensive than CAT-1
regimen.  Drugs available to treat MDR TB are  weak,
and have more adverse reactions.
Lungs of patients affected by TB, a single
founder strain of Mycobacterium Tuberculosis,
may undergo   mutagenesis during treatment,
leading to  drug resistance  independently  in
discrete  physical  locales, resulting in parallel
evaluation of heterogeneous sub-population of
drug resistant  bacilli .   Relying on  drug
susceptibility test of organisms isolated from
patient sputa may not provide an accurate
representation of the bacterial  susceptibility in
all sub-populations within the lung.
The growth of MTB  is well known to  occur
in proportion to  oxygen tension.  Thus another factor
contributing to the florid bacterial growth  seen at
the luminal surface of the cavity  could be  improved
access to oxygen in the micro-environment.
The risk of spreading infection to the other
sites  in the same patient and to non-infected persons
from an individual with cavitary tuberculosis is very
high.  There is difficulty in reaching adequate drug
concentration because of  lack of adequate circulation.
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In continuation of the pioneering work of
Finsen on treatment of skin TB by UV1 light and in
vitro reports on bactericidal effect of UV light on
tubercular bacilli2, Eshanchanov et al reported  the
use of UVA  radiation from nitrogen laser (337 mm)
for the treatment of patients with PTB3.  In vitro
experiments have also been   carried out to understand
the  therapeutic mechanism involved.  It has been
shown that nitrogen laser irradiation can inhibit
growth of tubercular bacilli particularly  at high
intensities4.  In vitro experiments have also provided
some evidence as potential implements of nitrogen
laser irradiation  on the immune system, e.g   nitrogen
laser irradiation was seen  to enhance the intra-
cellular  killing of  internalized  bacterial in  human
neutrophil5.  Nitrogen laser irradiation leads to
temporary  inactivation of  drug sensitive  as well as
drug resistant clinical isolates of  MTB6.  Laser
therapy improves the blood circulation and essentially
increases oxygen supply and so stimulates
mycobacteria  to reproduction, making infecting
agents relatively  easily available for anti-tubercular
drugs. The present study has been carried out to
describe the efficacy and safety of low level nitrogen
laser therapy in management of Chronic Drug
Resistant pulmonary tuberculosis.
MATERIAL  AND  METHODS
One hundred twenty two patients with  drug
resistance pulmonary tuberculosis admitted to  single
medical unit of  Department of Medicine ,M.G.M.
Medical College & M.Y.Hospital, Indore, over a  10
year period  from 1995 to 2004  were  included in a
retrospective  pattern.
The study was conducted with the consent
of all patients. Their detailed medical history and
physical examinations were taken from them and
included in the study conducted between age-group
15-65 years with diagnosis of drug resistant
tuberculosis.  Drug  resistance proven by (a) AFB
culture and sensitivity;  (b) received anti-tubercular
treatment for  more than 1 year  showing no response
and (c) presence of cavity in chest X-ray.
Baseline investigation included complete
haemogram , blood sugar ,  sputum examination for
presence of  acid   fast bacilli , AFB culture and
sensitivity , screen test for  human immunodeficiency
virus, Australia - antigen for  hepatitis - B virus,
Skiagram chest and CT chest.
Intra-cavitary laser irradiation
Intra-cavitary nitrogen laser was given at
the site of lesion or cavity.  Cavities  were localized
topographically using percussion and auscultation ,
chest radiography and CT scan were done to localize
the cavity.  The  anatomical site of entry was
localized between  the inter-costal space nearest to
the chest wall  and then the patient was positioned
accordingly, either sitting or supine, depending on
the site of puncture.  The patient was given 0.6 mg
of  atropine intra-muscularly 20 minutes before the
procedure.  With  all aseptic precaution, local
anesthesia was given  and a 10 ml  syringe  filled
with  normal  saline  and fitted with a 126 G 50 mm
jelco cannula was introduced at the site, negative
pressure was created by pulling back the piston while
pushing the needle forward.   Few bubbles of air
entry  into the syringe  confirmed the entry of the
jelco cannula  into the cavity.  The syringe with the
guide  needle was immediately withdrawn  and the
optical fibre was introduced and fixed at the site.
Laser machine started. 2mW nitrogen laser  was
given  for 780 sec, once weekly for  total 10 sittings.
The nitrogen laser used was  pulse nitrogen (2 mw
average power, at a wavelength of 337.1 nm, a
repetition rate of 10 Hz, energy per pulse of 10-30
µJ and a pulse width of 7 nanoseconds)  Nitrogen
laser  was coupled into a fibre optic  with a diameter
of 200 µm and an angle of divergence in the order
of 20o  would imply an energy density of  approx.
1.6 J/cm2  at the fibre tip and approx. 0.82 mJ/cm2
at a distance of 5 cm from the fibre tip assuming a
spherical cavity. Therefore,  780 seconds exposure
time results in dose of approx. 980 J/cm2 at the
fibre tip and approx. 492 mJ/cm2  at the distance of
5 cm from the tip. Appropriate statistical test of
significance was used  in analysis of  data (χ2 test )
 RESULTS
In the present study, 122 patients were
taken, including  61 patients in  nitrogen laser therapy
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group and  61 were kept  as control group. Male to
female ratio was 1.71:1. Mean age of patient was 30.78
(Table 1), mean duration of illness before receiving
therapy was 3.19 yrs. (Table 2). The most common
drug resistance  was found  to be of Isoniazid ,
followed by Pyrazinamide, Streptomycin and
Rifampicin.  In our study  least resistant was  found
to be of  Quinolone group (Ciprofloxacin ) (Figure-1).
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H   :  INH 
S    :  Streptomycin 
Pa  :  PAS 
T   :  Thiacetazone 
E    :  Ethambutol 
Z   :  Pyrazinamide 
R   :  Rifampicin 
K   :  Kanamycin 
Et  :  Ethionamide 
C   :  Ciprofloxacin 
LLT Group Control Group Duration      
(in months) No. % No. % 
12-24 29 47.54 37 60.65 
25-36 15 24.59 7 11.47 
37-48 3 4.91 6 9.83 
49-60 5 8.19 5 8.19 
> 5 yrs 9 14.75 6 9.83 
Total 61 100 61 100 
(z test, z=1.45; p> 0.05; Insignificant) 
LLT Group Control Group Age       
(in yrs.) No. % No. % 
15-25 20 32.78 21 34.42 
26-35 26 42.62 23 37.70 
36-45 11 18.03 11 18.03 
46-55 3 4.91 6 9.83 
56-65 1 1.63 0 0 
Total 61 100 61 100 
(z test, z=0.09; p> 0.10; Insignificant) 
Table 1: Age wise distribution of cases
among LLLT Group and Control
Group
Table 2: Duration of illness before receiving
treatment among LLLT Group and
Control Group
Fig: Pattern of drug resistance according to culture sensitivity report
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Table 3 shows that out of 61 patients, 44
(72.13%)  became  sputum smear and culture
negative for MTB among LLLT group as
compared to 26(42.62%) in control group. Among
LLLT group,  22 patients (50%) converted  within
1st month as compared to 7 cases (26.92) in
control group. Sputum conversion is faster  and
maximum  during the first month of  laser therapy
(50%).
Improvement was observed according to
drug resistance pattern (Table 4).  Of the 61 patients,
44 (72.13%) among LLLT group  as compared to
26(42.6%) in control group showed improvement.
Improvement was maximum in patients of single drug
resistance.
 LLLT group Control group 
Sputum Conversion 
Positives to negatives No. % No. % 
1st month 22 50.00% 7 26.92% 
2nd month 12 27.27% 9 34.61% 
5th month 6 13.63% 2 7.69% 
6th month 3 6.81% 5 19.24% 
8th month 1 2.27% 3 11.53% 
Total  44 72.13% 26 42.62% 
Not Improved  17 27.86% 35 57.37% 
Grand Total 61 100% 61 100% 
Sensitivity is 72.13%, specificity 57.37%, χ2 test; p value <0.05 
significant. 
Table 3: Time taken for sputum conversion in
LLLT Group and Control Group
                       LLLT Group                     CONTROL   
Drug Pattern Improved Not improved Total Improved Not improved Total 
Single drug 
resistance  12(85.71%) 2(14..28%) 14 5(71.42%) 2(28.57%) 7 
Two drugs 
resistance  7(70%) 3(30%) 10 5(50%) 5(50%) 10 
Three drugs 
resistance  7(70%) 3(30%) 10 6(40.00%) 9(60.00%) 15 
More than three  18(66.66%) 9(33.33%) 27 10(34.48%) 19(65.51%) 29 
Total  44(72.13%) 17(27.86%) 61 26(42.62%) 35(57.37%) 61 
Sensitivity is  72.13 %, specificity is 57.37 % , χ2 test; p <0.05 significant. 
 
LLLT GROUP CONTROL GROUP X-ray findings Improved Not improved Total Improved Not improved Total 
Single cavity  13(81.25%) 3(18.75%) 16 12(70.58%) 5(29.41%) 17 
Two cavities  3(75%) 1(25%) 4 1(33.33%) 2(66.66%) 3 
Multiple cavities with 
fibrosis 23(74.19%) 8(25.80%) 31 8(25%) 24(75%) 32 
Unilateral destroyed 
lung with F/C lesion 
opposite lung 
4(40%) 6(60%) 10 1(11.11%) 8(88.88%) 9 
Total  43(70.49%) 18(29.50%) 61 22(36.06%) 39(63.93%) 61 
Sensitivity  is  70.5% , specificity is 63.9% , χ2 test; p value is  < 0.05 significant.    
Table 4: Improvement according to Drug Resistance
Table 5: Improvement according to radiological findings
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Out of  61 patients, 43 (70.41%)  improved
radiologically  as compared to 22  (36.06%) in control
group (Table 5). Maximum improvement was seen
in single cavity. Radiological improvement was seen
in terms of  complete closure of cavity in 20% of
improved patients and  regression of cavity and
thinning of  the wall of cavity in 42.85% of improved
patients.  Rest of the patients’ cavity size remained
as such.
Five patients had slight Haemoptysis, 7
developed pneumothorax, all were managed
conservatively.
All patients,  who completed full course
of treatment, were followed up for an average
period of 3 years. Seven patients (11.47%)
showed  bacter io logical  re lapse  whi le  4
(6 .55%) re lapsed within  6  months  and 3
(4 .91%) re lapsed af ter  12 months  af ter
completion of  treatment.
DISCUSSION
Multi drug resistant  pulmonary
tuberculosis (MDR-PTB) is one entity  which
presently has no other  modality  of treatment
except the second line drugs   like Cycloserin,
Kanamycin, Ethionamide, Prothionamide, PAS  and
so on, which in a developing country like  India
is a costly affair.  Also  these drugs are not freely
available,  therefore the patients’ compliance
becomes poor. The use of  alternative modalities
of treatment for tuberculosis like UV radiation,
electrotherapy, and drugs like iodoform and
formaldehyde have been recognized for over one
hundred years.  Before the advent of
chemotherapeutic drugs, agents like iodoform and
formaldehyde have been used in treatment of
phthisis (tuberculosis) with some success.
Radioactive  agents such as radium thorium  have
also been used in treatment of tuberculosis as early
as 1903 by Soddy et al. Hence it was  proven that
apart from chemotherapeutic drugs,  alternative
modalities    of treatment have a role in treatment.
Although the exact mechanism by which
beneficial effects of LLLT observed in
tuberculosis is not known but it has been observed
that nitrogen laser irradiation  leads to temporary
inactivation of drug sensitive  as well as drug
resistant clinical isolate of MTB6. UVA  radiation
has been reported to lead to alteration in cell
membrane  properties via damage to membrane
lipid7-9. Nitrogen laser irradiation  alters the fluidity
of lipid region of the cell wall6.
Another important aspect concerning
Nitrogen laser irradiation (337nm)induced inactivation
of MTB  is  that UV (320-400nm)irradiation of cell
is known to lead to  generation of  oxygen radicals
as singlet oxygen photosensitized reaction involving
endogenous   photochromophore10.
Out of 61 patients, 44(72%)  became
sputum smear and culture negative for MTB in LLLT
group. Among those who achieved Bacteriological
conversion, 22 patients (50%)  converted within first
month as compared to  26.92 in control . Sputum
conversion rate is higher and faster in LLLT group
as compared to control group. Similar studies were
also conducted in Tashkent by Eshankhanov3 et al
and  in India by  Bhagwanani et al 11,Puri M.M.12,
yielding  similar results.
Maximum improvement was seen in
younger age group with resistant to one drug and
single cavity.  Patients who completed treatment were
followed up for 24 to 36 months.   7 patients showed
bacteriological relapse because of poor drug
compliance and multiple cavities.
Laser therapy for MDR-PTB is a  newer
modality of treatment which gives patients a  ray
of hope for better quality of life. Results are
encouraging and LLLT is well tolerated by the
patients.  Further work is now required to
evaluate the basic mechanism of action of laser
and optimize the parameter  as far as dose
delivery and duration of laser  irradiation is
concerned.
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